Latest profit margin
Spero Therapeutics Profit margin
Direct answer
Spero Therapeutics's profit margin is 15.71%.
The verified market snapshot reports 15.71%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 20, 2026.
Get free Spero Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Profit margin
- 15.71%
Explore related company data
View Spero Therapeutics's market capitalizationView Spero Therapeutics's p/e ratioView Spero Therapeutics's price-to-book ratioView Spero Therapeutics's return on equityView Spero Therapeutics's dividend yieldView Spero Therapeutics's 52-week price rangeView Spero Therapeutics's debt-to-equity ratioView all Spero Therapeutics key metricsReturn to Spero Therapeutics profile